Fig 4.tif (182.6 kB)
Hemodynamic impact of perflubron cycling.
figure
posted on 2018-01-29, 18:37 authored by Michaël Sage, Mathieu Nadeau, Claudia Forand-Choinière, Julien Mousseau, Jonathan Vandamme, Claire Berger, Jean-Sébastien Tremblay-Roy, Renaud Tissier, Philippe Micheau, Étienne Fortin-PellerinA. central venous pressure; B. Left ventricular end diastolic pressure; C. Negative dP/dt; D. Left ventricular relaxation time constant (tau); E. Mean systemic arterial pressure; F. Mean pulmonary arterial pressure.
